Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

Background: Lopinavir/ritonavir (LPV/r) is a major antiretroviral treatment in China, but little is known about the performance of first-line LPV/r-based regimen in treatment-naïve patients with human immunodeficiency virus type 1 (HIV-1) infection. This study aims to assess the efficacy and adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Bin, Wang, Yin, Zhou, Ruifeng, Jiang, Taiyi, Zhang, Hongwei, Li, Zaicun, Liu, An, Shao, Ying, Hua, Wei, Zhang, Tong, Wu, Hao, He, Shenghua, Dai, Lili, Sun, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920196/
https://www.ncbi.nlm.nih.gov/pubmed/31920659
http://dx.doi.org/10.3389/fphar.2019.01472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920196/
https://www.ncbi.nlm.nih.gov/pubmed/31920659
http://dx.doi.org/10.3389/fphar.2019.01472

Ejemplares similares